Globus Medical (GMED) Receivables (2011 - 2026)

Globus Medical's Receivables history runs 16 years deep, the most recent figure standing at $686.4 million for Q1 2026.

• Quarterly Receivables rose 28.28% year-over-year to $686.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $686.4 million (up 28.28% YoY) and the FY2025 annual result came in at $678.9 million, up 21.74% from the prior year.
• Receivables was $686.4 million for Q1 2026 at Globus Medical, up from $678.9 million in the prior quarter.
• Across five years, Receivables topped out at $686.4 million in Q1 2026 and bottomed at $166.2 million in Q1 2022.
• A 5-year average of $450.7 million and a median of $534.3 million in 2024 frame the typical range for Receivables.
• Annual changes were most pronounced in 2024 — Receivables surged 154.71% — and 2025, when it dropped 0.04%.
• Globus Medical's Receivables stood at $213.2 million in 2022, then jumped by 135.99% to $503.2 million in 2023, then advanced by 10.82% to $557.7 million in 2024, then increased by 21.74% to $678.9 million in 2025, then rose by 1.1% to $686.4 million in 2026.
• Business Quant data shows GMED's Receivables at $686.4 million in Q1 2026, $678.9 million in Q4 2025, and $619.1 million in Q3 2025.